» Articles » PMID: 32532082

Gene Expression Profiling in Fibromyalgia Indicates an Autoimmune Origin of the Disease and Opens New Avenues for Targeted Therapy

Overview
Journal J Clin Med
Specialty General Medicine
Date 2020 Jun 14
PMID 32532082
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Fibromyalgia is a chronic disorder characterized by widespread pain and by several non-pain symptoms. Autoimmunity, small fiber neuropathy and neuroinflammation have been suggested to be involved in the pathogenesis of the disease. We have investigated the gene expression profile in peripheral blood mononuclear cells obtained from ten patients and ten healthy subjects. Of the 545,500 transcripts analyzed, 1673 resulted modulated in fibromyalgic patients. The majority of these genes are involved in biological processes and pathways linked to the clinical manifestations of the disease. Moreover, genes involved in immunological pathways connected to interleukin-17 and to Type I interferon signatures were also modulated, suggesting that autoimmunity plays a role in the disease. We then aimed at identifying differentially expressed Long non-coding RNAs (LncRNAs) functionally connected to modulated genes both directly and via microRNA targeting. Only two LncRNAs of the 298 found modulated in patients, were able to target the most highly connected genes in the fibromyalgia interactome, suggesting their involvement in crucial gene regulation. Our gene expression data were confirmed by real time PCR, by autoantibody testing, detection of soluble mediators and Th-17 polarization in a validation cohort of 50 patients. Our results indicate that genetic and epigenetic mechanisms as well as autoimmunity play a pivotal role in the pathogenesis of fibromyalgia.

Citing Articles

Management of Fibromyalgia: Novel Nutraceutical Therapies Beyond Traditional Pharmaceuticals.

Antonelli A, Bianchi M, Fear E, Giorgi L, Rossi L Nutrients. 2025; 17(3).

PMID: 39940388 PMC: 11820827. DOI: 10.3390/nu17030530.


Role of Vitamin D Status and Alterations in Gut Microbiota Metabolism in Fibromyalgia-Associated Chronic Inflammatory Pain.

Saija C, Bertuccio M, Scoglio A, Macaione V, Cacciola F, Micalizzi G Biomedicines. 2025; 13(1).

PMID: 39857723 PMC: 11760899. DOI: 10.3390/biomedicines13010139.


Electroacupuncture Reduced Fibromyalgia-Pain-like Behavior through Inactivating Transient Receptor Potential V1 and Interleukin-17 in Intermittent Cold Stress Mice Model.

Yeh Y, Liao H, Hsiao I, Hsu H, Lin Y Brain Sci. 2024; 14(9).

PMID: 39335365 PMC: 11430684. DOI: 10.3390/brainsci14090869.


Inflammation, Autoimmunity, and Infection in Fibromyalgia: A Narrative Review.

Paroli M, Gioia C, Accapezzato D, Caccavale R Int J Mol Sci. 2024; 25(11).

PMID: 38892110 PMC: 11172859. DOI: 10.3390/ijms25115922.


Identification of unique genomic signatures in patients with fibromyalgia and chronic pain.

Mohapatra G, Dachet F, Coleman L, Gillis B, Behm F Sci Rep. 2024; 14(1):3949.

PMID: 38366049 PMC: 10873305. DOI: 10.1038/s41598-024-53874-8.


References
1.
Axtell R, de Jong B, Boniface K, van der Voort L, Bhat R, De Sarno P . T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med. 2010; 16(4):406-12. PMC: 3042885. DOI: 10.1038/nm.2110. View

2.
Salaffi F, Di Carlo M, Farah S, Atzeni F, Buskila D, Ablin J . Diagnosis of fibromyalgia: comparison of the 2011/2016 ACR and AAPT criteria and validation of the modified Fibromyalgia Assessment Status. Rheumatology (Oxford). 2020; 59(10):3042-3049. DOI: 10.1093/rheumatology/keaa061. View

3.
Boerma T, Harrison J, Jakob R, Mathers C, Schmider A, Weber S . Revising the ICD: explaining the WHO approach. Lancet. 2016; 388(10059):2476-2477. DOI: 10.1016/S0140-6736(16)31851-7. View

4.
Pathan M, Keerthikumar S, Ang C, Gangoda L, Quek C, Williamson N . FunRich: An open access standalone functional enrichment and interaction network analysis tool. Proteomics. 2015; 15(15):2597-601. DOI: 10.1002/pmic.201400515. View

5.
Sarzi-Puttini P, Atzeni F, Masala I, Salaffi F, Chapman J, Choy E . Are the ACR 2010 diagnostic criteria for fibromyalgia better than the 1990 criteria?. Autoimmun Rev. 2017; 17(1):33-35. DOI: 10.1016/j.autrev.2017.11.007. View